Literature DB >> 22172716

Stable IL-10: a new therapeutic that promotes tumor immunity.

Michele W L Teng1, Phillip K Darcy, Mark J Smyth.   

Abstract

In this issue of Cancer Cell, Mumm et al. demonstrate that pegylated IL-10 increases CD8(+) T cell numbers, IFN-γ secretion, and cytotoxicity in established tumors, enhancing antigen presentation machinery and suppressing tumor growth. This approach may enhance T cell immune responses in cancers with reduced T cell infiltration.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Year:  2011        PMID: 22172716     DOI: 10.1016/j.ccr.2011.11.020

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  14 in total

1.  Editorial: protean effects of IL-10 include skin self-defense.

Authors:  Daniel H Fowler
Journal:  J Leukoc Biol       Date:  2012-08       Impact factor: 4.962

2.  Novel Fish Oil-based Bigel System for Controlled Drug Delivery and its Influence on Immunomodulatory Activity of Imiquimod Against Skin Cancer.

Authors:  Khurram Rehman; Mohd Hanif Zulfakar
Journal:  Pharm Res       Date:  2016-09-12       Impact factor: 4.200

3.  Diabetes-associated dysregulated cytokines and cancer.

Authors:  Yong Wu; Yanjun Liu; Yunzhou Dong; Jay Vadgama
Journal:  Integr Cancer Sci Ther       Date:  2016-02-15

Review 4.  Preventing Colorectal Cancer through Prebiotics.

Authors:  Manijeh Mahdavi; Isabelle Laforest-Lapointe; Eric Massé
Journal:  Microorganisms       Date:  2021-06-18

5.  Therapeutical measures to control airway tolerance in asthma and lung cancer.

Authors:  Katerina Andreev; Anna Graser; Anja Maier; Stephanie Mousset; Susetta Finotto
Journal:  Front Immunol       Date:  2012-07-26       Impact factor: 7.561

6.  Inflammatory events during murine squamous cell carcinoma development.

Authors:  Thais Helena Gasparoto; Carine Ervolino de Oliveira; Luisa Thomazini de Freitas; Claudia Ramos Pinheiro; Rodrigo Nalio Ramos; André Luis da Silva; Gustavo Pompermaier Garlet; João Santana da Silva; Ana Paula Campanelli
Journal:  J Inflamm (Lond)       Date:  2012-11-23       Impact factor: 4.981

7.  The prognostic influence of tumor infiltrating Foxp3(+)CD4(+), CD4(+) and CD8(+) T cells in resected non-small cell lung cancer.

Authors:  Jurgita Jackute; Marius Zemaitis; Darius Pranys; Brigita Sitkauskiene; Skaidrius Miliauskas; Vytis Bajoriunas; Simona Lavinskiene; Raimundas Sakalauskas
Journal:  J Inflamm (Lond)       Date:  2015-11-23       Impact factor: 4.981

8.  Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.

Authors:  Murali R Kuracha; Peter Thomas; Brian W Loggie; Venkatesh Govindarajan
Journal:  Cancer Med       Date:  2016-02-02       Impact factor: 4.452

9.  Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner.

Authors:  Surajit Pathak; Wen-Jian Meng; Suman Kumar Nandy; Jie Ping; Atil Bisgin; Linda Helmfors; Patrik Waldmann; Xiao-Feng Sun
Journal:  Oncotarget       Date:  2015-12-29

10.  Interleukin-10-regulated tumour tolerance in non-small cell lung cancer.

Authors:  Julius Malte Vahl; Juliane Friedrich; Susanne Mittler; Sonja Trump; Lisanne Heim; Katerina Kachler; Liubov Balabko; Nicole Fuhrich; Carol-Immanuel Geppert; Denis Iulian Trufa; Nina Sopel; Ralf Rieker; Horia Sirbu; Susetta Finotto
Journal:  Br J Cancer       Date:  2017-10-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.